Melatonin in Alzheimer’s Disease
Alzheimer’s disease (AD), an age-related neurodegenerative disorder with progressive cognition deficit, is characterized by extracellular senile plaques (SP) of aggregated β-amyloid (Aβ) and intracellular neurofibrillary tangles, mainly containing the hyperphosphorylated microtubule-associated prote...
Main Authors: | Jian-Zhi Wang, Qing Tian, Jiang Chu, Shu-Sheng Yang, Qiong-Xia Huang, Li Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/7/14575 |
Similar Items
-
Curcuminoids and resveratrol as anti-Alzheimer agents
by: Oliver B. Villaflores, et al.
Published: (2012-12-01) -
Natural Products in Alzheimer’s Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
by: Solomon Habtemariam
Published: (2019-04-01) -
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
by: Saghar Rabiei Poor, et al.
Published: (2021-09-01) -
Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures
by: Runxuan Lin, et al.
Published: (2020-05-01) -
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)